Tanabe KK, Jara S, Michaelson JS Creating and Providing Predictions of Melanoma Outcome, Ann Surg Oncol, 2010 (Linked version is a pre-publication proof)

Michaelson JS,Chen LL, Silverstein M Mihm MV, Jr., Sober AJ, Tanabe KK, Smith BL, Younger J. How Cancer at The Primary Site And In The Nodes Contributes To The Risk Of Cancer Death, CANCER Nov 1;115(21):5095-107 2009 (Linked version is a preprint of the published article now available at CancerOnline)

Michaelson JS,Chen LL, Silverstein M, Cheongsiatmoy JA, Mihm MV, Jr., Sober AJ, Tanabe KK, Smith BL, Younger J. Why Cancer at The Primary Site And In The Nodes Contributes To The Risk Of Cancer Death CANCER Nov 1;115(21):5084-94 2009 (Linked version is a preprint of the published article now available at CancerOnline)

Chen LL, Nolan, M, Silverstein M, Mihm MV, Jr., Sober AJ, Tanabe KK, Smith BL, Younger J., Michaelson JS, The Impact Of Primary Tumor Size, Nodal Status, And Other Prognostic Factors On The Risk Of Cancer Death CANCER 2Nov 1;115(21):5071-83 2009 (Linked version is a preprint of the published article now available at CancerOnline)

Rusby JE, Kirstein LJ, Brachtel EF, Michaelson JS, Koerner FC, Smith BL Nipple-sparing mastectomy: Lessons from ex-vivo procedures The Breast Journal. In press 2007

Dominguez FJ, Golshan M, Black DM, Hughes KS,Gadd MA, Christian R, Lesnikoski B, Specht M, Michselson JS, Smith BL Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma in Situ Ann Surgical Oncology In Press 2007

Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, Khuri SF, Tanabe KK. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg.

Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RC, Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN, Abdalla EK, Curley SA, Choti MA, Elias D. Liver-Directed Surgery for Metastatic Squamous Cell Carcinoma to the Liver: Results of a Multi-Center Analysis. Ann Surg Oncol.

Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FC, Muzikansky A, Sober AJ, Tanabe KK, M.D. Melanoma of the young: differences and similarities with adult melanoma, a case-matched controlled analysis Cancer Aug 1;110(3):614-24 2007

Michaelson J, Reducing Delay in the Detection and Treatment of Breast Cancer. Adv Imag Onc In Press 2007

Michaelson J, Mammographic Screening: Impact on Survival in CANCER IMAGING Ed: M.A. Hayat in press 2007

Rusby JE, Brachtel EF, Michaelson JS, Koerner FC, Smith BL. Breast Duct Anatomy in the Human Nipple: Three-Dimensional Patterns and Clinical Implications Breast Cancer Research and Treatment Jan 2007

Zabicki K, Colbert JA, Dominguez FJ, Gadd MA, Hughes KS, Jones JL, Specht MC, Michaelson JS, Smith BL. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol.

Michaelson JS, Cheongsiatmoy JA Dewey F, Silverstein M, Sgroi D Smith B. Tanabe KK, The Spread of Human Cancer Cells Occurs with Probabilities Indicative of A Non Genetic Mechanism British Journal of Cancer 93:1244-1249 2005

Livestro DP, Muzikansky A, Kaine EM, Flotte TJ, Sober AJ, Mihm MC Jr, Michaelson JS, Cosimi AB, Tanabe KK. A Case-Control Study of Desmoplastic Melanoma J Clin Oncol. 2005 Sep 20;23(27):6739-46.

Dominguez FJ, Jones JL, Zabicki K, Smith BL, Gadd MA, Specht M, Kopans DB, Moore RH, Michaelson JS, Hughes KS. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer.

Jagsi R, Raad RA, Goldberg S, Sullivan T, Michaelson J, Powell SN, Taghian AG. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys.

Blanchard K, Colbert J, Kopans D, Moore R, Halpern E, Hughes K, Tanabe K, Smith BL, Michaelson JS. The Risk of False Positive Screening Mammograms, as a Function of Screening Usage. RADIOLOGY, 240: 335 - 342 2006

Colbert, J Bigby JA, Smith D, Moore R, Rafferty E, Georgian-Smith D, D'Alessandro HA, Yeh E, Kopans DB, Halpern E, Hughes K, Smith BL, Tanabe KK, Michaelson J. The Age at Which Women Begin Mammographic Screening. CANCER: 101, 1850-1859

Jones JL, Hughes KS, Kopans DB, Moore RH, Howard-McNatt M, Hughes SS, Lee NY, Roche CA, Siegel N, Gadd MA, Smith BL, Michaelson JS. Evaluation of hereditary risk in a mammography population. Clin Breast Cancer.

Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell.

Blanchard K, Weissman J, MoyB, PuriD, Kopans D,, , Kaine E, MooreR, Halpern E, Hughes K, Tanabe K, Smith B Michaelson J, Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival Cancer 101, 495-507 2004

Jagsi R, Powell S, Raad RA, Goldberg S, Michaelson J, Taghian A Loco-regional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy alone: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 57:S128-9 2003

Chen Y, Taghian A, Goldberg S, Assaad S, Abi Raad R, Michaelson J, Powell S Influence of margin status and tumor bed boost dose on local recurrence rate in breast-conserving therapy: does a higher radiation dose to the tumor bed overcome the effect of close or positive margin status in breast-conserving therapy? Int J Radiat Oncol Biol Phys 57:S358 2003

Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe KK, Smith B The effect of tumor size and lymph node status on breast carcinoma lethality. CANCER 98:2133-43 2003

Michaelson JS, Satija S, Kopans DB, Moore RA, Silverstein, M, Comegno A, Hughes K, Taghian A, Powell S, Smith, B Gauging the Impact of Breast Cancer Screening, in Terms of Tumor Size and Death Rate Cancer 98:2114-24 2003

del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J Racial differences in mammographic breast density. CANCER 98:590-6 2003

Michaelson JS Satija S, Moore R Weber G Garland G Kopans DB, Hughes, K. Estimates of the Sizes at which Breast Cancers Become Detectable on Mammographic and on Clinical Grounds Journal of Women's Imaging 5:10-19 2003

Michaelson JS Satija S, Moore R Weber G Garland G Kopans DB Estimates of the Breast Cancer Growth Rate and Sojourn Time from Screening Database Information Journal of Women's Imaging 5:3-10 2003

Beckett JR, Kotre CJ, Michaelson JS Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme. Br J Radiol 76:309-20 2003

Michaelson JS Silverstein M, Wyatt J Weber G Moore R Kopans DB, Hughes, K. Predicting the survival of patients with breast carcinoma using tumor size CANCER 95: 713-723 2002

Michaelson JS Satija S, Moore R Weber G Garland G Phuri, D. Kopans DB The Pattern of Breast Cancer Screening Utilization and its Consequences CANCER 94:37-43 2002

Michaelson JS Satija S Moore R Weber G Garland G Kopans DB, Observations on Invasive Breast Cancers Diagnosed in a Service Screening and Diagnostic Breast Imaging Program Journal of Woman's Imaging 3:99-104 2001

Cady, B. Michaelson, JS, The life-sparing potential of mammographic screening. Cancer 91:1699-703 2001

Michaelson JS Using Information on Breast Cancer Growth, Spread, and Detectability to Find the Best Ways To Use Screening to Reduce Breast Cancer Death Woman's Imaging 3:54-57 2001

Michaelson, JS, Kopans, DB, Cady, B. The Breast Cancer Screening Interval is Important. Cancer 2000 88:1282-1284

Michaelson, J. The Role Of Molecular Discreteness In Normal And Cancerous Growth. Anticancer Research.

Michaelson, J, Halpern, E, Kopans, D. A Computer Simulation Method For Estimating The Optimal Intervals For Breast Cancer Screening. Radiology.

Giorda R Hagiya M Seki T Shimonishi M Sakai H Michaelson J Francavilla A Starzl TE Trucco M Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 2:97-108 1996

Estelle Newton, Yung Chyung, Pil Kang, Nancy Bucher, David Andrews, James Kurnick, Albert DeLeo, Abdul Rao, Massimo Trucco, Thomas E. Starzl, James S. Michaelson The Immunofluorescence Visualization Of ALR (Augmenter Of Liver Regeneration) Reveals Its Presence In Platelets And Male Germ Cells

Kumagai-Braesch, Schacter, B. Yan, 3Z, Michaelson, J., et al. The cross-reactivity of anti-human adhesion antibodies to primate and swine cells. et. al.

Kumagai-Braesch, Schacter, B. Yan, Z, Michaelson, J., et al. Identification of Swine and Primate Cellular Adhesion Molecules (CAM)Using Mouse Anti-Human Monoclonal Antibodies. 1995

Michaelson, J. Cell Selection in the Genesis of Multicellular Organization Lab Invest. 69: 136-150 1993.

Sakamoto H, Michaelson J, Jones WK, Bahn AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara J. Lymphocytes with a novel CD4+, CD8-, CD3- phenotype are effectors of experimental GVHD. Proc. Acad. Sci.

Michaelson J. The significance of cell death. In: Apoptosis (Eds Cope F.O., Tomlei, L.D.).

Salant E, Michaelson J. TL.8. A new antigenic determinant of the TL system.

Perkins DL, Flaser RM, Mahon CA, Michaelson J, Marshak-Rothstein A. Evidence for an intrinsic B-cell defect in lpr/lpr mice apparent in neonatal chimeras. J. 1990; 145:549-559

Ferrara JLM, March P. Michaelson J, Burakoff J. Anti-asialo GM1 in vivo improves engraftment of T cell depleted marrow in semiallogeneic mice.

Anderson D, Michaelson J, Johnson D. The monoclonal antibody 316, which recognizes polymorphic antigens expressed on human trophoblast, testicular germ cells and capacitated sperm. Biology of Reproduction, 1989; 41:285-293.

Michaelson J. Qa/T1a antigens. In: Human Immunogenetics (Litwin S., Ed.), 1988.

Whitehead AS, Rits M, Michaelson J. Molecular genetics of mouse ser3um amyloid P component (SAP): cloning and gene mapping. Immunogenetics 1988; 28:388-390.

Ferrara LM, Michaelson J, Burakoff SJ, Mauch P. Engraftment following bone marrow transplantation III differential effects of increased total body irradiation of hybrid and allogeneic recipients. Transplantation 1988; 45:448-452.

Perkins DL, Michaelson J, Marshak-Rothstein A. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-versus-host disease. J Immunol.

Michaelson J. Cell selection in development. Biological Reviews 1987; 62:115-139.

Ferrara JLM, McIntry J, Michaelson J, Mauch P, Burakoff SJ. Engraftment following T cell depleted marrow transplantation. II. Transplantation 1987; 44:495-499.

Perkins D, Michaelson J, Marshak-Rothstein A2. The lpr gene is associated with failure of engraftment of radiation chimeras with lymphoid but not erythroid stem cells. J Immunol.

Michaelson J, Boyse EA, Ciccia L, Flaherty L, Fleissher E, Hammerling U, Lawrence M, Mach P, Shen FW. Biochemical genetics of TL antigens. Immunogenetics 1986; 24:103-114.

Bushkin Y, Tung FW, Pinter A, Michaelson J, Boyse EA. Unusual association of 2-microglobulin with certain Class I heavy chains of the major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83:432.

Lynes MA, Flaherty L, Michaelson J, Collins JJ, Rinchik EM. Allogeneic reactivity in normal mouse seru2m. J Immunogenet.

D'Eustachio P, Fein B, Michaelson J, Taylow BA. The alpha-globin pseudogene on mouse chromosome 17 is closely linked to H-2. J Exp Med.

Michaelson J, Boyse EA, Chorney M, Flaherty L, Fleisner I, Hammerling U, Reinisch C, Rosenson R, Shen F. The biochemical genetics of the Qa-T1a region. Transplant Proc.

Michaelson J. Genetics of 2-microglobulin in the mouse. Immunogenetics 1983; 17:2192-259.

Michaelson J, Flaherty L, Hutchinson B, Yudkowitz H. Qa-2 does not display structural genetic polymorphism detectable on isoelectric-focusing gels. Immunogenetics 1982; 16:363-366.

Chorney M, Shen FW, Michaelson J, Boyse EA. Monoclonal antibody to alloantigenic determinant on 2-microglobulin (2m) of the mouse. Immunogenetics 1981; 16:91-93.

Michaelson J, Bushkin Y, Flaherty L, Hammerling U, Boyse EA. Biochemical genetics of TL antigens on mouse thymocytes. Eur J Imm.

Michaelson J, Bushkin Y, Flaherty L, Boyse EA. Further biochemical data on Qa-2. Immunogenetics 1981; 14:129-140.

Michaelson J, Ferreira A, Nussenzweig V. Demonstration of cis-interacting genetic elements in the S regions of the murine major histocompatibility complex. Nature 1981; 289:306.

Michaelson J. Genetic polymorphism of 2-microglobulin (2m), maps to the H-3 region of chromosome 2. Immunogenetics 1980; 13:167.

Michaelson J, Rothenberg E, Boyse EA.: A genetic polymorphism of murine 2-microglobulin detected biochemically. Immunogenetics 1980; 11:93.

McIntyre K, Uhr J, Vitetta E, Hammerling U, Michaelson J, Flaherty L, Boyse, EA. Analysis of thymus-leukemia (TL) antigens using monoclonal antibodies. J Immunol.

Ferreira A, Michaelson J, David C, Nussenzweig, V. Identification of the H-2.7 specificity as an antigen determinant of C4. Fed. 19801; 39:809.

Ferreira A, Michaelson J, Nussenzweig V. H-2 linked polymorphism of the gamma chain of the murine slp proteins. Immunogenetics.

Ferreira A, Michaelson J, Nussenzweig V. Polymorphism of the gamma chain of murine Ss (C4) and Slp proteins. Immunobiol.

Kincade P, Flaherty L, Lee G, Watanabe T, Michaelson J. Presence of the Qa-2 alloantigen on functional lumphoid, myeloid and stem cells in ad1ult mice. J Immunol.

Michaelson J, Artzt K, Bennett D, Caldwell J, Heath J. A cell surface antigen, TER, expressed on embryos and germ cells. J Immunol.

Michaelson J, Scheid M, Boyse EA. Biochemical features of Ly-5 alloantigen. Immunogenetics 1979; 9:193.

Michaelson J, Flaherty L, Vitetta E, Boyse EA. Biochemical demonstration of anti-Qa activity 1in an H-2.28 public specificity anti-serum. Immunogenetics 1978; 7:265.

Michaelson J, Flaherty L, Vitetta LS, Boyse EA. Similartities between the Qa-2 alloantigen and other gene products of the 17th chromosome of the mouse. J Exp Med.

Tung J, Michaelson J, Sato H, Vitetta LS, Boyse EA. Properties of the Lyb-2 molecules. Immunogenetics 1977; 5:485.